Related Experiment Video
Updated: Aug 25, 2026

Retinal Pathophysiological Evaluation in a Rat Model
Published on: May 6, 2022
[Role of insulin-like growth factor I in the development of diabetic retinopathy]
Małgorzata Gacka1, Joanna Adamiec
1Katedra i Klinika Angiologii, Nadciśnienia, Tetniczego i Diabetologii, Akademii Medycznej we Wrocławiu.
Abstract:
Diabetic retinopathy is one of the main causes of blindness. This review will discuss the role of IGF-I in the pathogenesis of diabetic retinopathy. IGF-I is a growth factor with a very wide spectrum of biological activities. It especially controls cell growth and metabolic processes. Disorders of IGF-I activity, which are observed during diabetes, contribute to pathologic vascularization of the eye, particularly in the retina. Reasons for this is local hypoxia, which results from chronic hyperglycaemia; damage of blood retina barrier and disorder of the axis IGF-I--growth hormone. In the first stage of diabetic retinopathy the deficit of the systemic IGF-I can also be of importance. The role of IGF-I in diabetic retinopathy enables better understanding, and thus in the future better intensive antidiabetic therapy in aspect of ophthalmic complications.
More Related Videos
Related Concept Videos
Diabetic Retinopathy
Insulin: The Receptor and Signaling Pathways
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

